All patients with DM who receive treatment with insulin, and certain patients treated with oral hypoglycemic agents that can cause hypoglycemia (essentially secretagogue drugs), need to have regular checks of glucose concentrations so as to maintain an appropriate metabolic control. This evidence concerns the gene INS and Hypoglycemia.